Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015563 |
---|---|
Receipt number | R000018084 |
Scientific Title | Phase II study to examine efficacy prediction of Regorafenib with FDG-PET/CT in patients with treatment-refractory metastatic colorectal cancer |
Date of disclosure of the study information | 2014/11/01 |
Last modified on | 2021/01/18 23:08:47 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/10/30 10:54:08 | ||
2 | Update | 2016/11/15 13:42:51 | Key inclusion criteria |
|
3 | Update | 2016/11/15 13:43:42 | Name of primary person or sponsor Organization |
|
4 | Update | 2016/11/15 13:45:46 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results |
|
5 | Update | 2021/01/18 23:08:47 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Address TEL Address Address TEL Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization Address1 Tel1 Email1 Organization Organization Address Address Tel Institutions |